Specifically, we assessed whether, in human IBD samples, the expression of BRD4 correlates with IL-34 content; analyzed which cells co-express the two molecules; and whether the knockdown of BRD4 in IBD LPMC is followed by a reduction in IL-34 production. The gene discussed is IL34; the disease is inflammatory bowel disease.